This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
MHRA.Yellow Cards which made a difference - high-dose rosuvastatin and rhabdomyolysis. Drug Safety Update 5: Y1, No. 4, Nov 2011. Available from: URL: http://www.mhra.gov.uk
About this article
Cite this article
Rosuvastatin: Yellow Card reports provide early signal. React. Wkly. 1380, 2 (2011). https://doi.org/10.2165/00128415-201113800-00003
- Rare Case
- Safety Issue
- Product Characteristic